Trials / Withdrawn
WithdrawnNCT01551446
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the variability of several pharmacodynamic measures of kidney function, cardiovascular function, cerebral perfusion, and haemodynamics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bardoxolone Methyl | Oral, once daily |
Timeline
- Start date
- 2012-04-30
- Primary completion
- 2012-11-30
- Completion
- 2012-11-30
- First posted
- 2012-03-12
- Last updated
- 2025-05-29
Source: ClinicalTrials.gov record NCT01551446. Inclusion in this directory is not an endorsement.